BusinessCyclotek and Telix Pharmaceuticals Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New ZealandBy Nasdaq OMXJul 31, 2017, 4:59 AM UTC
BusinessTESARO and Takeda Enter Into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Therapy Niraparib in JapanBy Nasdaq OMXJul 27, 2017, 11:01 AM UTC
BusinessPeregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent DevelopmentsBy Nasdaq OMXJul 14, 2017, 8:13 PM UTC
BusinessCascadian Therapeutics Announces Positive Regulatory Update for Tucatinib in EuropeBy Nasdaq OMXJul 11, 2017, 12:01 PM UTC
BusinessOncology Venture and Eisai Forge Exclusive Global License Agreement for Clinical Stage Oncology Drug PARP Inhibitor E7449 / 2X-121By Nasdaq OMXJul 7, 2017, 12:30 PM UTC
BusinessActinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ETBy Nasdaq OMXJul 6, 2017, 11:30 AM UTC
BusinessTESARO Joins OCRFA as Presenting Sponsor of the 2017 Ovarian Cancer National ConferenceBy Nasdaq OMXJun 29, 2017, 1:00 PM UTC
